Neogenin is a member of the N-CAM family of cell adhesion molecules and is closely related to the DCC tumor suppressor gene product. Recently, it has been demonstrated that the DCC/Neogenin subfamily plays a key role in axonal guidance within the embryonic nervous system, however little is known about the function of DCC or Neogenin in non-neuronal tissues in vertebrates. To gain an understanding of Neogenin function outside of the nervous system we have cloned and sequenced the mouse homologue of Neogenin. We describe three alternatively spliced exons within the extracellular domain of Neogenin and a fourth alternatively spliced exon within the cytoplasmic domain. We further demonstrate that three of these alternatively spliced exons are developmentally regulated. Analysis of Neogenin mRNA expression showed that two distinct Neogenin transcripts are expressed at signi®cant levels in a broad spectrum of adult mouse tissues and throughout the mid to late stages of embryogenesis. In situ hybridization studies on day 15.5 mouse embryos revealed that Neogenin is expressed widely throughout the developing mouse embryo, in both neuronal and nonneuronal tissues. These observations suggests that Neogenin may play an integral role in regulating dierentiation programmes and/or cell migration events within many embryonic and adult tissues.
Introduction
The release of cells from their normal growth and dierentiation programs leads to the continuous, unregulated proliferation underlying tumorigenesis. Over recent years, cell adhesion molecules (CAMs) have been shown to in¯uence signal transduction pathways that regulate both mitogenesis and differentiation (Juliano, 1996; Huber et al., 1996) . Homophilic interaction of the E-cadherin CAM on opposing cells controls the availability of the signal transducing molecule, b-catenin (Huber et al., 1996) . Loss of Ecadherin adhesive activity at the cell surface releases bcatenin into the cytoplasm where it complexes with the LEF-1 transcription factor resulting in increased transcriptional activity (Huber et al., 1996) . Mutations in the E-cadherin gene have been shown to contribute to tumour progression in gynecologic and breast cancers (Risinger et al., 1994; Berx et al., 1995) .
Engagement of integrin CAMs also stimulates signal transduction pathways controlling cell growth. Loss of integrin-ligand interaction at the cell surface has been demonstrated to result in anchorage-independent growth of transformed cells, perhaps through the down-regulation of apoptotic mechanisms (Ruoslahti and Reed, 1994) . Thus, loss of adhesion activity can lead to the unchecked proliferation driving tumorigenesis.
Loss of heterozygosity at the DCC (Deleted in Colorectal Cancer) gene locus has been observed in greater than 70% of all colorectal cancers studied (Fearon et al., 1990) . In addition, loss of DCC gene expression has also been demonstrated in a wide variety of other metastatic cancers (Devilee et al., 1991; Huang et al., 1992; Uchino et al., 1992; HoÈ hne et al., 1992; Gao et al., 1993; Scheck and Coons, 1993; Por®ri et al., 1993; Miyake et al., 1993; Gima et al., 1994; Enomoto et al., 1995) . The extracellular domain of the DCC gene product is comprised of four immunoglobulin (Ig)-like domains and six ®bronectin type III (Fn III) repeats, placing DCC in the Neural Cell Adhesion Molecule (N-CAM) family of Ig-like CAMs. A second closely related molecule, Neogenin, also containing four Ig domains and six Fn III repeats, was identi®ed by Vielmetter et al. (1994) in chick embryonic day 18 cerebellum. Together, these two molecules de®ne a distinct subfamily of N-CAMlike cell adhesion receptors. Both DCC and Neogenin are expressed in the developing murine central nervous system and in the developing gut of the chick embryo (Chuong et al., 1994; Vielmetter et al., 1994; Cooper et al., 1995; Keino-Masu et al., 1996) . In the adult, DCC is expressed predominately in the central nervous system of the human and mouse. In addition, low levels of DCC expression have also been observed in some epithelial tissues including the gut of the chicken, the human colon, and the mouse bladder (Chuong et al., 1994; Hedrick et al., 1994; Reale et al., 1994, respectively) . Although the presence of Neogenin protein has been demonstrated in adult chicken brain (Vielmetter et al., 1994) , its expression pattern in non-neural tissues of the adult has not yet been reported.
Recently, a homologue of DCC and Neogenin has been isolated in Caenorhabditis elegans (UNC-40) and also in Drosophila melanogaster (Frazzled) (Kolodziej et al., 1996) . Loss-offunction mutants in both species demonstrated that the DCC/Neogenin homologue is responsible for axonal guidance within the developing nervous system Kolodziej et al., 1996) . Studies on axonal guidance with rat neural tube explants further demonstrated that a diusable axonal guidance cue, chicken netrin-1, directly interacted with rat DCC resulting in the stimulation of neurite outgrowth and commissural axon guidance along the netrin gradient (Keino-Masu et al., 1996) . Rat Neogenin was also reported to directly bind chicken netrin-1, however its role in axonal guidance has not yet been elucidated (Keino-Masu et al., 1996) . The observation that high levels of Neogenin expression are correlated with the onset of neuronal dierentiation (Vielmetter et al., 1994) suggests that Neogenin may also play a role in the terminal dierentiation of neurons.
At present, however, it is unclear how the loss of expression of the DCC gene product contributes to the malignant phenotype of colorectal cancer. To better understand the function of the DCC/Neogenin subfamily of CAMs in non-neural tissues of the embryo and adult we have cloned and sequenced the mouse homologue of Neogenin (mNeogenin). We describe three alternatively spliced exons within the extracellular domain of mNeogenin which have not previously been described and con®rm a fourth alternatively spliced exon, initially described by Vielmetter et al. (1994) , within the cytoplasmic domain. We further demonstrate that three of these alternatively spliced exons are developmentally regulated. Two distinct mNeogenin mRNA species are expressed at signi®cant levels in a large variety of adult mouse tissues. High levels of these mNeogenin transcripts were also observed in the mid to late stages of mouse gestation. In situ hybridization studies on day 15.5 mouse embryo sections revealed that mNeogenin is expressed widely throughout the developing mouse embryo, in both neuronal and nonneuronal tissues. Therefore, our observations suggest that Neogenin may function as a cell adhesion molecule in a broad spectrum of embryonic and adult tissues.
Results
The nucleotide and predicted amino acid sequence of mouse Neogenin
The mouse Neogenin (mNeogenin) nucleotide sequence was derived from 18 independent overlapping cDNA clones isolated from embryonic day 10 and 15 (E10 and E15) mouse embryo cDNA libraries, and from newborn and adult mouse brain cDNA libraries. Sequencing of these 18 clones revealed the existence of four distinct alternatively spliced exons (see below). Figure 1 shows the complete nucleotide sequence and predicted amino acid sequence of mNeogenin. Since the previously published chicken sequence (Vielmetter et al., 1994) did not include the initiation codon, the Nterminal amino acid sequence could not be determined. In contrast to the chicken sequence, the amino acid sequence presented in Figure 1 contains 45 additional residues at the N-terminus which include the initiation methionine, a predicted 38 amino acid leader sequence, and the ®rst seven residues of the mature protein. The mNeogenin nucleotide sequence encodes an uninterrupted open reading frame between the predicted initiation codon at bp 181 and the poly-A tail at bp 5397. The predicted initiation codon at bp 181 is surrounded by a strong Kozak consensus sequence for initiation of translation (Kozak, 1991) . The mNeogenin protein, including those segments speci®ed by the alternatively spliced exons, is predicted to encode a 1493 amino acid protein comprised of a putative 38 amino acid hydrophobic leader sequence, followed by an extracellular domain of four V-like Ig domains (see Discussion) and six Fn III repeats. A 337 amino acid cytoplasmic domain follows a predicted transmembrane domain of 26 hydrophobic amino acids. Based on the predictions of von Heijne (1986) , the mature protein is expected to begin at alanine 39. The expected molecular weight of mature mNeogenin (1455 amino acids) in the absence of glycosylation is 159 kD. Analysis of the mNeogenin amino acid sequence using the PROSITE data base identi®ed eight N-linked glycosylation sites (N-X-S/T) in the extracellular domain (Figure 1 ).
Mouse Neogenin mRNA is expressed throughout embryogenesis and ubiquitously in adult mouse tissues
To determine the expression of mNeogenin in the adult we carried out Northern blot analysis on poly(A) + RNA from a large variety of adult tissues. The BR11 cDNA clone, encompassing the last four Fn III repeats, the transmembrane domain, and the ®rst 165 bp of the cytoplasmic domain of mNeogenin, was used as the mNeogenin-speci®c probe. Hybridization with this probe revealed two distinct mNeogenin transcripts of approximately 6.6 kb and 5.1 kb which were expressed at high levels in all adult tissues examined ( Figure 2a) . Hybridization with the rat GAPDH probe demonstrated the comparative loading of RNA in all lanes (Figure 2b) . mNeogenin was expressed at signi®cant levels in all adult tissues examined including liver, stomach, spleen, lung, ovary, heart, thymus, brain, small intestine, skeletal muscle and kidney. In each adult tissue the shorter transcript was expressed in higher abundance than the longer transcript by a factor of two, or three, to one.
Members of the N-CAM family of cell adhesion molecules have been shown to play essential roles in embryogenesis, especially during the development of the central nervous system (Walsh and Doherty, 1996; Tessier-Lavigne and Goodman, 1996) . To determine whether mNeogenin is expressed during embryogenesis, Northern blot analysis was carried out on poly(A) + RNA prepared from mouse embryos at mid to late stages of gestation. Figure 3 demonstrates that both the 6.6 kb and 5.1 kb mNeogenin transcripts were expressed at signi®cant levels in E11.5 and E18.5 embryos. Further analysis of mNeogenin mRNA expression in E9.5 ± E18.5 embryos demonstrated that the expression pattern seen for E11.5 and E18.5 embryos was typical for all days of gestation examined (data not shown). Therefore, two distinct mNeogenin mRNA transcripts are expressed ubiquitously throughout the mid to late stages of gestation and in all tissues of the adult mouse examined.
Mouse Neogenin is expressed in the central nervous system and connective tissues of the developing embryo
To determine the pattern of mNeogenin expression in mouse development, in situ hybridization was performed using a 1.6 kb anti-sense mNeogenin 33 Plabelled riboprobe transcribed from clone BR11 Figure 1 The nucleotide and predicted amino acid sequences of mouse Neogenin. The predicted amino acid sequence begins at bp 181 and the putative initiation codon is designated amino acid position 1. The ®rst amino acid of the mature protein is predicted to be amino acid 39. The four alternatively spliced exons are underlined. The conserved cysteines and tryptophans de®ning the V-like Ig domains are circled. The conserved W-X-X-P motif within each ®bronectin type III repeat is boxed. Potential N-linked glycosylation sites are marked with an asterisk. The transmembrane domain is enclosed within the black box. The Genbank/EMBL Nucleotide Sequence Database accession number for the mouse Neogenin nucleotide and amino acid sequences is Y09535 ( Figure 4a ). The speci®city of the hybridization signal generated by the anti-sense mNeogenin riboprobe was demonstrated by hybridization of negative and positive control 33 P-labelled riboprobes to adjacent E15.5 sections. Firstly, the mNeogenin sense riboprobe yielded no detectable positive signal ( Figure 4b ). Secondly, an antisense riboprobe speci®c for mouse DCC produced the expected hybridization pattern for that gene product and was distinct from that observed for the anti-sense mNeogenin probe (data not shown). Therefore, all control probes used in this experiment gave hybridization signals distinct from that observed for our anti-sense mNeogenin probe demonstrating the stringency of the hybridization protocol employed.
Neogenin was found to be widely expressed throughout the developing embryo. In a sagittal section of an E15.5 mouse embryo ( Figure 4a ) mNeogenin was observed throughout the developing central nervous system. In particular, high levels of expression were seen in the ventricular zone of the mesencephalon but not in the mantle region. Although not visible in Figure 4a , strong Neogenin expression was also observed in the ventricular zone of the rhombencephalon while the mantle region remained negative (data not shown). Neogenin mRNA was also (Figure 4a ), including the ventricular zone (data not shown). In the telencephalon, expression was observed throughout the cortical plate and intermediate zone of the neocortex. However, in contrast to the mesencephalon, no expression was seen in the ventricular zone of the neocortex. Strong expression was also observed in the olfactory bulb, while the thalamus and the hypothalamus showed weak expression. Low levels of Neogenin mRNA were also observed in the pons and cerebellum.
In addition, mNeogenin was present in connective tissue throughout the embryo with a strong signal present in areas of condensations of connective tissue. This is particularly evident in the supportive tissue of the developing lung, the cartilage of the limb buds, and the cartilage of the developing nasal structures ( Figure  4a ). In transverse sections of E15.5 embryos mNeogenin mRNA was also observed at signi®cant levels in the mesentery, which is the supportive tissue of the gut (data not shown).
Alternatively spliced exons of mouse Neogenin are developmentally regulated
In sequencing the 18 independent mNeogenin cDNA clones we identi®ed four distinct splice variants. We have con®rmed the presence of an alternatively spliced exon in the cytoplasmic domain which was originally described for chicken Neogenin by Vielmetter et al. (1994) . In addition, we have identi®ed three alternatively spliced exons in the extracellular domain that have not been previously characterized. We have designated these alternative exons 1, 2, 3 and 4 in order of their 5' to 3' occurrence in the nucleotide sequence. The position of each alternatively spliced exon is underlined in Figure 1 . To determine the pattern of expression for each of the splice variants in adult mouse tissues (brain, colon, testis, spleen, ovary, liver, lung, kidney, thymus, stomach, muscle, heart) and throughout the mid to late stages of embryogenesis we carried out RT ± PCR using oligonucleotide primer pairs spanning the alternatively spliced regions ( Figure 5 ).
Alternative Exon 1 A 60 bp deletion, spanning bp 1505 to 1564, was observed in three of ®ve clones isolated from the E15 cDNA library. This deletion corresponded to amino acids 442 to 461 which are situated between the fourth Ig domain and the ®rst Fn III repeat ( Figure 5 ). RT ± PCR employing the mouse primer pair 9523/9524 ( Figure 5 ) generated two PCR products of 390 bp and 330 bp throughout all days of embryogenesis ( Figure 6 ). The size of the larger PCR product corresponded to that predicted from the nucleotide sequence shown in Figure 1 , while deletion of the 60 bp alternatively spliced exon was expected to yield a 330 bp fragment. The relative abundance of both splice variants did not appear to vary signi®cantly throughout gestation (Figure 6 ). RT ± PCR analysis of adult tissues indicated that both forms of mNeogenin were also expressed equally in each tissue examined (data not shown).
Alternative Exon 2 While all clones isolated from the newborn mouse library encoded the nucleotide sequence shown in Figure 1 , one clone (BR11) isolated E10.5 E11.5 E12.5 E13.5 E14.5 E15.5 E16.5 E17.5 Figure 6 Expression patterns of the four alternatively spliced exons of mNeogenin throughout the mid to late stages of gestation. RT ± PCR analysis of ®rst strand cDNA derived from total RNA from E9.5 through E17.5 embryos, using the speci®c primer pairs described in Materials and methods from the adult brain library and two clones derived from the E15 library lacked a 48 bp segment encoding 16 amino acids (amino acids 863 ± 878) between the fourth and ®fth Fn III repeats ( Figure 5 ). To demonstrate that this deletion was the result of a true alternative splicing event, RT ± PCR was carried out on embryonic and adult tissues using the primer pair 9099/ 9100 ( Figure 5 ). The expected length of the PCR product in the presence of the 48 bp exon was 190 bp while that expected in the absence of this exon was 142 bp. Figure 6 demonstrates that in all embryonic days tested both PCR products were present. Cloning and sequencing of these PCR products demonstrated that they contained the expected nucleotides sequences.
There was a marked dierence in the relative abundance of the 142 bp and 190 bp PCR fragments at dierent days of gestation indicating that the splicing of alternative exon 2 was developmentally regulated (Figure 6 ). At E9.5, E10.5, and E17.5 the dominant mRNA isoform was that in which this exon was deleted. However, between E11.5 and E16.5, the transcript including alternative exon 2 was upregulated with respect to the transcript lacking this exon. Analysis of adult tissues by RT ± PCR demonstrated that both isoforms were ubiquitously expressed throughout the adult mouse. In all cases, the isoform lacking alternative exon 2 predominated (data not shown).
Alternative Exon 3 Although the majority of clones encoding the region N-terminal to the transmembrane domain were identical to the nucleotide sequence shown in Figure 1 , two clones from the newborn mouse library and two clones from the E10 library contained a 33 bp deletion (bp 3435 ± 3467). This deletion corresponded to an 11 amino acid segment (amino acids 1086 ± 1096) situated between the sixth Fn III repeat and the transmembrane domain ( Figure  5 ). RT ± PCR ampli®cation using the primer pair 9116/9117 ( Figure 5 ) was expected to generate a product of 341 bp in the presence of alternative exon 3, and a 308 bp product in its absence. Figure 6 shows that both PCR products were present from E11.5 through to E17.5. However, the isoform containing alternative exon 3 was not detected in E9.5 or E10.5 embryos. The expression of alternative exon 3 was regulated during embryogenesis in a similar fashion to alternative exon 2. The highest relative expression of the isoform including alternative exon 3 was observed between days 11.5 and 16.5 of gestation whereas the expression of this exon was signi®cantly reduced compared to the isoform lacking this exon in both early (E9.5 and E10.5) and late (E17.5) day embryos. The mNeogenin transcript which did not contain this alternatively spliced exon was observed in all adult tissues studied. Cloning and sequencing of both PCR products con®rmed that the 341 bp PCR product included alternative exon 3 while the 308 bp product lacked this sequence.
Alternative Exon 4 Vielmetter et al. (1994) described a 159 bp alternatively spliced exon in the cytoplasmic domain of chicken Neogenin. We have also observed this splice variant (alternative exon 4) in two clones, one isolated from the E10 library and one from the E15 library. This alternatively spliced exon encodes a 53 amino acid sequence (amino acids 1279 ± 1331) which lies in the central region of the cytoplasmic domain ( Figure 5 ). RT ± PCR analysis of E9.5 through E17.5 embryo cDNAs, using the primer pair 9421/ 9423 ( Figure 5 ) generated two fragments of 383 bp and 224 bp, corresponding to the predicted sizes in the presence and absence of alternative exon 4, respectively ( Figure 6 ). Again, expression of this alternatively spliced exon was developmentally regulated. Overall, the isoform containing alternative exon 4 was the predominant isoform observed from E9.5 through to E17.5. Both mNeogenin transcripts were expressed ubiquitously in all adult tissues studied, although the isoform containing this exon was expressed at signi®cantly lower levels than the isoform containing alternative exon 4 (data not shown). In summary, mNeogenin has four alternatively spliced exons, three of which are situated in the extracellular domain and one in the cytoplasmic domain. We have further demonstrated that the expression of alternative exons 2, 3 and 4 are developmentally regulated. Between E11.5 and E16.5, transcripts containing alternative exons 2 or 3 were found to be up-regulated relative to transcripts lacking these alternative exons. In addition, the transcript lacking alternative exon 4 was up-regulated relative to the transcript containing alternative exon 4 over this same period of gestation.
Discussion
Our limited understanding of the function of the DCC/Neogenin subfamily of Ig-like CAMs derives mostly from studies on axonal guidance in the embryonic nervous system (Keino-Masu et al., 1996; Chan et al., 1996; Kolodziej et al., 1996) . DCC was initially described as a major tumor suppressor gene contributing to the malignant phenotype of colorectal cancer in humans (Fearon et al., 1990) . However, little is known about the role of DCC or Neogenin in nonneuronal tissues in vertebrates. To gain an understanding of Neogenin function outside of the central nervous system we have cloned and sequenced the mouse homologue of Neogenin. Both Neogenin and DCC are comprised of four V-like Ig domains and six Fn III repeats. Initially, the Ig domains of both DCC and Neogenin were classi®ed as C2-like Ig domains on the basis of the conserved primary sequence motifs present in each domain (Williams and Barclay, 1988) . Recently however, Vaughn and Bjorkman have employed tertiary structure-based sequence alignments to predict the most likely Ig-fold (C1, C2, or V-like) adopted by many N-CAM family members (Vaughn and Bjorkman, 1996) . This new analysis has led to the reclassi®cation of the Ig domains within these molecules, including DCC and Neogenin, as being V-like rather than C2-like Ig domains (Vaughn and Bjorkman, 1996) . Overall, the amino acid sequence of Neogenin is highly conserved in vertebrates. mNeogenin is 96.2% identical to rat Neogenin (Genbank accession number; U68726) and 92.8% identical to human Neogenin (Meyerhardt et al., 1997) at the amino acid level, whilst chicken Neogenin is 86% identical (Vielmetter et al., 1994) . The degree of homology between mNeogenin and mouse DCC across their entire length is 46%. The highest degree of similarity between these molecules lies within the fourth Ig domain (71%) and the fourth Fn III repeat (70%). In contrast, the cytoplasmic domains of mNeogenin and mouse DCC are less conserved (28%) suggesting that they may interact with distinct sets of cytoplasmic proteins.
The axonal guidance function of rat DCC has been shown to be activated by direct interaction with the diusable guidance cue, netrin-1 (Keino- Masu et al., 1996) . It has also been reported that rat Neogenin can bind netrin-1 (Keino-Masu et al., 1996) . Since the highest level of sequence conservation between DCC and Neogenin is found in the fourth Ig domain and in the fourth Fn III repeat it is likely that the netrin-1 binding site on Neogenin and DCC involves one of these domains. While netrin-1 expression is mainly restricted to the central nervous system in the adult chicken, a second netrinlike molecule, netrin-2, is expressed in a variety of posthatch (gut, heart, and lung) and adult tissues (lung, spleen, and ovary) . In the mouse we have observed high levels of mNeogenin mRNA in these adult tissues (Figure 2 ) suggesting that the putative mouse netrin-2 homologue may be a mNeogenin ligand in some nonneural tissues. Strong expression of mNeogenin in adult tissues that do not express netrins implies that additional Neogenin ligands exist. The phenotype generated by mutagenesis at the DCC/Neogenin locus in C. elegans was found to be more extensive than that seen in netrin mutants alone (Hedgecock et al., 1990) . These observations also suggest that other DCC/Neogenin ligands remain to be discovered. Since the netrins have strong homology to the laminin g chain it is possible that mNeogenin may interact with laminin-like molecules in non-neuronal tissues. Neogenin may also interact with its close relative, DCC, or other N-CAM family members expressed on opposing cells. In addition, like many other members of the N-CAM family, mNeogenin may be a homotypic CAM.
Our studies have revealed that a variety of alternatively spliced forms of mNeogenin are coexpressed throughout the mid to late stages of embryogenesis and in most adult tissues. Northern blot analysis demonstrated the existence of two distinct mNeogenin transcripts (5.1 kb and 6.6 kb) in all adult and embryonic tissues analysed (Figures 2  and 3) . Two transcripts were also observed for chicken and human Neogenin (Vielmetter et al., 1994; Meyerhardt et al., 1997, respectively) . The relationship between these transcripts is not clear. The four alternatively spliced exons identi®ed within the coding region of mNeogenin ( Figure 5 ) are relatively small and so do not account for the 1.5 kb size dierence between the two mRNA species. Since no other large alternatively spliced exons were identi®ed within the mNeogenin coding region it is most likely that the two mNeogenin transcripts represent alternative splicing events in the 5' or 3' untranslated regions or usage of dierent polyadenylation sites.
We have identi®ed three new alternatively spliced exons within the extracellular domain of mNeogenin and con®rmed a fourth alternatively spliced exon in the cytoplasmic domain which was initially described in chicken Neogenin (Vielmetter et al., 1994) ( Figure  5 ). All adult tissues examined expressed mNeogenin mRNA species which included alternatively spliced exons 1, 2, and 4, as well as mRNA transcripts that excluded each of these alternative exons. The expression of the mRNA transcripts containing alternatively spliced exons 2, 3, and 4 were found to be developmentally regulated (Figure 6 ). It is interesting to note that DCC also contains a 60 bp alternatively spliced exon in exactly the same position as the mNeogenin alternative exon 2 (Reale et al., 1994; Cooper et al., 1995) . The amino acid sequences of the DCC and mNeogenin alternative exons are highly divergent (16.7% identity) suggesting that this region within DCC and mNeogenin has distinct functions. The expression of this alternative exon within DCC is also regulated throughout embryogenesis in an identical pattern to that seen for mNeogenin alternative exon 2 but it is not observed in adult mouse tissues (Cooper et al., 1995) .
Developmentally regulated, alternatively spliced forms of N-CAM are also known to exist (Miragall et al., 1988; Zorn and Krieg, 1992) . Expression of the VASE exon, encoding 10 amino acids situated in the fourth Ig domain, is not observed in neurons early in development. In contrast, up to 50% of N-CAM transcripts in neurons of the central nervous system in the adult contain this exon (Small and Akeson, 1990) . Inclusion of the VASE sequence leads to loss of N-CAM-dependent neurite outgrowth activity while the cell adhesion function of N-CAM is unaected (Saell et al., 1994) . Interaction of N-CAM with the ®broblast growth factor (FGF) receptor on the same membrane is required for activation of the signal transduction cascade which drives N-CAM-dependent neurite outgrowth (Williams et al., 1994) . The VASE sequence has been shown to speci®cally inhibit this interaction presumably by preventing N-CAM molecules (not containing VASE) from binding to the FGF receptor (Williams et al., 1994; Saell et al., 1994) . Similarly, the alternatively spliced exons in the extracellular domain of mNeogenin may modulate the interaction between mNeogenin and cell surface-bound proteins important for signal transduction. Although a variety of alternatively spliced isoforms of mNeogenin are expressed in each tissue we do not yet know whether the dierent isoforms are co-expressed in the same cell type within a given tissue. Co-expression of dierent mNeogenin isoforms may regulate Neogenin activity as in the case of N-CAM. Expression of alternative extracellular sequences may also modulate ligand speci®city.
DCC expression in the murine embryonic central nervous system is restricted to postmitotic neurons within the neural tube where it acts as an axonal guidance receptor (Keino-Masu et al., 1996: Gad, Keeling, Wilks, Tan and Cooper, manuscript submitted) . In contrast, mNeogenin appears to be involved in the very early events leading to neuronal dierentiation. We have observed strong expression of mNeogenin in the ventral region of the ventricular zone of the E15.5 mouse neural tube as well as in the ventricular zones of the mesencephalon (Figure 4 ) and rhombencephalon (data not shown). In E13 rat neural tube Neogenin is also localized to the ventral region of the ventricular zone (Keino-Masu et al., 1996) . Within the ventricular zone, neuroepithelial stem cells divide and dierentiate into early neuronal precursors (O'Leary and Koester, 1993) . Therefore, Neogenin may play a role in the initial dierentiation events leading to the generation of neural precursors within the ventricular zone. In support of this contention, high levels of Neogenin protein have been correlated with the onset of terminal dierentiation of neurons in the developing chick retina and cerebellum. Once this dierentiation process was complete Neogenin expression was then down-regulated in these regions (Vielmetter et al., 1994) .
That mNeogenin also plays an important role in the morphological events taking place outside of the central nervous system is demonstrated by its nonneuronal expression pattern in E15.5 mouse embryos (Figure 4 ). High levels of mNeogenin transcripts were seen in several mesodermal derived tissues including the connective tissues of the limb bud, lung and gut. Clues to the function of Neogenin in these tissues may be gleaned from the non-neural eects of DCC/ Neogenin mutations in C. elegans (Hedgecock et al., 1990) . In these mutants perturbation of ventral mesodermal migration patterns was frequently observed implying that the DCC/Neogenin homologue in C. elegans is also a guidance molecule for mesodermal cell migration.
Overall, Neogenin is expressed in embryonic tissues that are undergoing signi®cant morphological change and hence may be involved in cell migration and/or dierentiation events throughout embryogenesis. We have also demonstrated that a variety of dierent mNeogenin isoforms are expressed in a broad spectrum of adult mouse tissues. Therefore, a similar role for Neogenin can be envisioned in adult tissues. Preliminary evidence suggests that DCC may also be involved in the dierentiation of stem cell populations within several epithelial tissues within the adult (Chuong et al., 1994) . Therefore, the DCC/Neogenin subfamily of CAMs may play an integral role in regulating the dierentiation programmes and/or cell migration events within many adult and embryonic tissues.
Materials and methods

Cloning and sequencing of mouse Neogenin
A 677 bp fragment of mNeogenin (NG1) was initially used to screen an adult mouse brain DNA library. This cDNA probe was obtained by reverse transcriptasepolymerase chain reaction (RT ± PCR) ampli®cation of mouse E9.5 cDNA. The oligonucleotides employed to amplify the mNeogenin fragment were derived from the published chicken mNeogenin sequence (Vielmetter et al., 1994) . The sequences for the forward and reverse oligonucleotide primers were 8020 (chick bp 2773 ± 2793: 5'-ACG TGG AGC ATG ACA GCA CAT-3') and 8021 (chick bp 3430 ± 3450: 5'-ATG GAT CCA AAG GTC AGG AGG-3'), respectively. In this instance, we have designated the nucleotide sequence positions for the PCR primers in accordance with the chicken Neogenin nucleotide sequence reported by Vielmetter et al. (1994) . Assignment of all other sequence positions in this paper will be based on the mNeogenin nucleotide sequence shown in Figure 1 . The conditions used to amplify NG1 were: denaturation 958C 1 min, annealing 558C 2 min, extension 728C 2 min, 40 cycles. The NG1 fragment encoded the sixth Fn III repeat, the transmembrane domain and the ®rst 97 bp of the cytoplasmic domain of mNeogenin (bp 3088 ± 3745). The NG1 fragment was cloned into the EcoRV site of pBluescript KS + (Stratagene, San Diego, CA). The dideoxy-chain termination method (Sanger et al., 1977) was used to sequence all cDNA clones and PCR fragments. All sequencing was carried out on an automated sequencer (Applied Biosystems Inc, CA).
NG1 was used to screen a lGT11 phage library (both oligo-dT and random primed) constructed from adult mouse brain cDNA (Clontech, Palo Alto, CA). Library screening, phage puri®cation and preparation of phage DNA were carried out according to protocols given in Current Protocols in Molecular Biology (Ausubel et al., 1996) . Three clones were obtained, spanning bp 2170 to the poly-A tail (bp 5397) (Figure 1) . A 1.6 kb fragment (BR11), spanning bp 2170 ± 3815, was then used to screen a lShlox 2 cDNA library (oligo-dT primed) constructed from E10 whole mouse embryos (Novagen, Madison, WI). Two independent clones were obtained, spanning bp 2800 to the poly-A tail. BR11 was also used to screen a lZAP 1 II cDNA library (oligo-dT and random primed) constructed from newborn mouse brain (Stratagene, La Jolla, CA). Three overlapping clones spanning bp 2560 ± 4241 were obtained.
In order to obtain a clone encoding the 5' end of mNeogenin, including the initiation codon, we employed RT ± PCR. The forward primer, 9144 (5'-GAT GAT CGA CGC CAG CTT CTC-3'), was derived from the human Neogenin sequence obtained from the Non-Redundant Database of Genbank EST Division, I.M.A.G.E. cDNA clone 321525, (gb W32752\W32752\zc06d11.r1) and corresponded to bp 505 ± 525 of the mouse sequence (Figure 1) . The reverse primer (8755: bp 2166 ± 2186: 5'-TGA GGA GCA GCA CTG GGA ACA-3') was derived from the mouse cDNA sequence (Figure 1) . A 1.7 kb fragment (NG20) was obtained by RT ± PCR ampli®cation of mouse E9.5 cDNA (denaturation 948C 30 s, annealing 558C 2 min, extension 728C 3 min, 40 cycles). NG20 was subcloned into pBluescript KS + and the nucleotide sequence determined. This clone encoded bp 504 ± 2190 of mNeogenin. NG20 was digested to produce a subclone (bp 504 ± 1047) (NG600) which was used to screen a lgt11 phage library (Clontech, Palo Alto, CA) constructed from mouse E15 embryos. Ten independent clones were isolated, subcloned into pBluescript KS + , and subsequently sequenced. Four of these clones contained the predicted initiation methionine and two clones encoded fulllength mNeogenin.
In summary, the mNeogenin nucleotide sequence ( Figure  1 ) was constructed from 18 independent clones derived from four dierent cDNA libraries. Analysis of sequence data was carried out using the DNAStar Sequence analysis programme (DNAStar Inc., WI).
Northern blot analysis
Preparation of Poly(A) + RNA All mouse embryonic and adult tissues were obtained from mice housed in the Ludwig Institute for Cancer Research animal facility. Total RNA was isolated using the acid-guanadinium thiocyanate-phenol-chloroform method (Chowczynski and Sacchi, 1987) . The integrity of all RNA preparations was assessed on 1% denaturing agarose gels (1% agarose, 50% formaldehyde, 20 mM MOPS pH 6.8, 1 mM EDTA, 5 mM sodium acetate). Poly(A) + mRNA was puri®ed from 200 mg of total RNA using oligo-dT cellulose (Type II) (Collaborative Biomedical, MA) as described by Aviv and Leder (1972) .
Northern blot analysis Northern blot analysis was carried out using a randomly primed, 32 P-dATP-labelled, cDNA probe synthesized using the MegaPrime cDNA Labelling Kit (Amersham, UK). The 1.6 kb BR11 (bp 2170 ± 3815) mNeogenin clone was used as the template for synthesis of the probe. 1 mg of E11.5 and E18.5 poly(A) + RNA, and 5 ± 10 mg of adult tissue poly(A) + RNA (denatured for 5 min at 658C) was run in each lane of a denaturing agarose gel (1% agarose, 50% formaldehyde, 20 mM MOPS pH 6.8, 1 mM EDTA, 5 mM sodium acetate). The RNA was then transferred to GeneScreen Plus nylon membrane (DuPont, NEN, MA) via capillary action. The membrane was prehybridized for 1 h at 428C in 50% deionized formamide; 1 M NaCl; 1% SDS; 10% dextran sulphate (BDH Chemicals, Australia). The 32 P-dATPlabelled probe was then added to the mixture and incubated for 16 h at 428C. The membrane was washed twice with 26SSC (3 M NaCl, 0.3 M Na 3 citrate, pH 7.0) at room temperature for 5 min and then washed further to a ®nal stringency of 0.56 SSC and 0.5% SDS at 658C to remove unbound probe. Hybridized bands were visualized using the Molecular Dynamics PhosphorImager. To determine the comparative quantity of mRNA loaded across all lanes, the membrane was hybridized with a randomly primed, 32 P-dATP-labelled rat GAPDH probe.
RT ± PCR ampli®cation of alternatively spliced exons
Mouse tissue cDNA was synthesized from 2 mg of total RNA using the First Strand cDNA Synthesis Kit (Amersham, UK). RT ± PCR was carried out on embryonic and adult mouse cDNA using splice variant speci®c oligonucleotides as described below. The presence of the PCR products was assessed by U.V.-transillumination of ethidium bromide stained 4% agarose gels. Each set of RT ± PCR ampli®cations was repeated at least four times.
Alternative Exon 1 Oligonucleotides used were 9523 (bp 1345 ± 1363: 5'-GGG GAT GTG GTT ATC CCC A-3') and 9524 (bp 1644 ± 1664, 5'-GAT GCA GGT GTA CGC CAT GTC-3'); denaturation 948C 30 s, annealing 558C 1 min, extension 728C 1 min, 25 cycles.
Alternative Exon 2 Oligonucleotides used were 9099 (bp 2719 ± 2739: 5'-GGC GAA GGC ATC CCC CTT TAT-3') and 9100 (bp 2888 ± 2908: 5'-GGG AGT TGT CTG CCC AGG TGG-3'); denaturation 948C 30 s, annealing 558C 1 min, extension 728C 30 s, 25 cycles.
Alternative Exon 3 Oligonucleotides used were 9116 (bp 3203 ± 3223: 5'-GGC AGC CTC CCT CTG AAG CTA-3') and 9117 (bp 3523 ± 3543: 5'-GTT GCT GCC ACT CAT TGG AGG 3'); denaturation 948C 30 s, annealing 558C 1 min, extension 728C 30 s, 25 cycles.
Alternative Exon 4 Oligonucleotides used were 9241 (bp 3921 ± 3941: 5'-AGG GCA TGA GTC AGA GGA CAG-3') and 9243 (bp 4283 ± 4303: 5'-AGT CTT CCT CTT GGG AGC TGG-3'); denaturation 948C 30 s, annealing 588C 1 min, extension 728C 30 s, 25 cycles.
In situ hybridization
In situ hybridization was performed using the protocol described by JM Gad, SL Keeling, AF Wilks, S-S Tan, HM Cooper (manuscript submitted). A 1.6 kb 33 P-dUTPlabelled riboprobe was synthesized using clone BR11 (bp 2170 ± 3815) as the template for both the anti-sense and sense riboprobes. One mg of template was used to transcribe the sense and anti-sense probes employing the Bresatec Message Maker Kit according to the manufacturer's instructions (Bresatec, Adelaide, Australia). Before hybridization, the riboprobes were subjected to mild alkaline hydrolysis to reduce the probe length to approximately 100 bp.
Mouse embryos were obtained from timed matings of ICR mice housed in the Ludwig Institute Animal Facility. Embryonic day one (E1) was set at 24 h after the dark period when the animals were initially mated. The subsequent developmental stages of embryos were determined according to Kaufman (1992) . E15.5 embryos were collected after perfusion of the mother with 4% paraformaldehyde in PBS by injection into the left ventricle of the heart (Bolam, 1992) .
